255 related articles for article (PubMed ID: 6933468)
21. Investigation of the intrachromosomal position of the ADA locus on chromosome 20 by gene dosage studies.
Aitken DA; Ferguson-Smith MA
Cytogenet Cell Genet; 1978; 22(1-6):514-7. PubMed ID: 752533
[No Abstract] [Full Text] [Related]
22. Adenosine deaminase deficiency.
Hirschhorn R
Immunodefic Rev; 1990; 2(3):175-98. PubMed ID: 2078332
[TBL] [Abstract][Full Text] [Related]
23. Regional mapping of ADA and ITP on human chromosome 20: cytogenetic and somatic cell studies in an X/20 translocation.
Mohandas T; Sparkes RS; Passage MB; Sparkes MC; Miles JH; Kaback MM
Cytogenet Cell Genet; 1980; 26(1):28-35. PubMed ID: 7371431
[TBL] [Abstract][Full Text] [Related]
24. Paradoxical expression of adenosine deaminase in T cells cultured from a patient with adenosine deaminase deficiency and combine immunodeficiency.
Arredondo-Vega FX; Kurtzberg J; Chaffee S; Santisteban I; Reisner E; Povey MS; Hershfield MS
J Clin Invest; 1990 Aug; 86(2):444-52. PubMed ID: 1974554
[TBL] [Abstract][Full Text] [Related]
25. Correction of adenosine deaminase deficiency in cultured human T and B cells by retrovirus-mediated gene transfer.
Kantoff PW; Kohn DB; Mitsuya H; Armentano D; Sieberg M; Zwiebel JA; Eglitis MA; McLachlin JR; Wiginton DA; Hutton JJ
Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6563-7. PubMed ID: 3489233
[TBL] [Abstract][Full Text] [Related]
26. Identical 3250-bp deletion between two AluI repeats in the ADA genes of unrelated ADA-SCID patients.
Berkvens TM; van Ormondt H; Gerritsen EJ; Khan PM; van der Eb AJ
Genomics; 1990 Aug; 7(4):486-90. PubMed ID: 1696926
[TBL] [Abstract][Full Text] [Related]
27. A high proportion of ADA point mutations associated with a specific alanine-to-valine substitution.
Markert ML; Norby-Slycord C; Ward FE
Am J Hum Genet; 1989 Sep; 45(3):354-61. PubMed ID: 2773932
[TBL] [Abstract][Full Text] [Related]
28. Severe combined immune deficiency due to a homozygous 3.2-kb deletion spanning the promoter and first exon of the adenosine deaminase gene.
Berkvens TM; Gerritsen EJ; Oldenburg M; Breukel C; Wijnen JT; van Ormondt H; Vossen JM; van der Eb AJ; Meera Khan P
Nucleic Acids Res; 1987 Nov; 15(22):9365-78. PubMed ID: 3684597
[TBL] [Abstract][Full Text] [Related]
29. Isolation of cDNA clones for human adenosine deaminase.
Valerio D; Duyvesteyn MG; Meera Khan P; Geurts van Kessel A; de Waard A; van der Eb AJ
Gene; 1983 Nov; 25(2-3):231-40. PubMed ID: 6198240
[TBL] [Abstract][Full Text] [Related]
30. Adenosine deaminase deficiency in combined immunologic deficiency disease.
Meuwissen HJ; Pickering RJ; Pollara B
Birth Defects Orig Artic Ser; 1975; 11(1):117-9. PubMed ID: 1148375
[TBL] [Abstract][Full Text] [Related]
31. Lack of adenosine deaminase deficiency in the mutant mouse wasted.
Geiger JD; Nagy JI
FEBS Lett; 1986 Nov; 208(2):431-4. PubMed ID: 3780980
[TBL] [Abstract][Full Text] [Related]
32. Normal and mutant human adenosine deaminase genes.
Akeson AL; Wiginton DA; Hutton JJ
J Cell Biochem; 1989 Mar; 39(3):217-28. PubMed ID: 2651461
[TBL] [Abstract][Full Text] [Related]
33. Identification of a point mutation in the adenosine deaminase gene responsible for immunodeficiency.
Bonthron DT; Markham AF; Ginsburg D; Orkin SH
J Clin Invest; 1985 Aug; 76(2):894-7. PubMed ID: 3839802
[TBL] [Abstract][Full Text] [Related]
34. Adenosine deaminase deficiency and immunodeficiencies.
Hirschhorn R
Fed Proc; 1977 Jul; 36(8):2166-70. PubMed ID: 872949
[TBL] [Abstract][Full Text] [Related]
35. Expression of human adenosine deaminase using a transmissable murine retrovirus vector system.
Friedman RL
Proc Natl Acad Sci U S A; 1985 Feb; 82(3):703-7. PubMed ID: 3856223
[TBL] [Abstract][Full Text] [Related]
36. Adenosine deaminase complexing protein (ADCP): a transformation sensitive protein with potentials of a cancer marker.
Herbschleb-Voogt E; Ten Kate J; Meera Khan P
Anticancer Res; 1983; 3(2):95-100. PubMed ID: 6133497
[TBL] [Abstract][Full Text] [Related]
37. Erythrocyte adenosine deaminase deficiency without immunodeficiency. Evidence for an unstable mutant enzyme.
Hirschhorn R; Roegner V; Jenkins T; Seaman C; Piomelli S; Borkowsky W
J Clin Invest; 1979 Oct; 64(4):1130-9. PubMed ID: 479373
[TBL] [Abstract][Full Text] [Related]
38. Expression of human adenosine deaminase in mice reconstituted with retrovirus-transduced hematopoietic stem cells.
Wilson JM; Danos O; Grossman M; Raulet DH; Mulligan RC
Proc Natl Acad Sci U S A; 1990 Jan; 87(1):439-43. PubMed ID: 2296599
[TBL] [Abstract][Full Text] [Related]
39. Adenosine deaminase (ADA) deficiency due to deletion of the ADA gene promoter and first exon by homologous recombination between two Alu elements.
Markert ML; Hutton JJ; Wiginton DA; States JC; Kaufman RE
J Clin Invest; 1988 May; 81(5):1323-7. PubMed ID: 3366897
[TBL] [Abstract][Full Text] [Related]
40. Basic molecular defect in ADA-SCID.
Herbschleb-Voogt E; Scholten JW; Vossen JM; Pearson PL; Meera Khan P
Adv Exp Med Biol; 1984; 165 Pt A():381-4. PubMed ID: 6720406
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
